Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Completing one ...

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

The analysis included 1103 people (aged 52 to 85 years) who died from colorectal adenocarcinoma between 2011 and 2017, and 9608 controls. HealthDay News — Screening with fecal immunochemical tests ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

Sensitivity varied from 10.1 to 36.7%, and specificity varied from 85.5 to 96.6% for advanced colorectal neoplasia. HealthDay News — Fecal immunochemical tests (FITs) have variable sensitivity and ...

Please provide your email address to receive an email when new articles are posted on . People in rural areas experience a variety of barriers to CRC screening. A mailed fecal immunochemical test ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Younger vs. older patients achieved a higher rate of ...

When it comes to colorectal cancer, there are several tests used for screening which one to choose depends on the patient. The best test is the one that gets done and done. Well, Dr Cke Dalba with the ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...